Short Interest in Grail, Inc. (NASDAQ:GRAL) Expands By 18.6%

Grail, Inc. (NASDAQ:GRAL) saw a significant growth in short interest in December. As of December 31st, there was short interest totalling 5,810,000 shares, a growth of 18.6% from the December 15th total of 4,900,000 shares. Approximately 20.2% of the shares of the stock are sold short. Based on an average daily trading volume, of 773,500 shares, the short-interest ratio is presently 7.5 days.

Grail Stock Performance

Shares of NASDAQ:GRAL traded up $0.01 during trading on Friday, hitting $17.42. The company’s stock had a trading volume of 483,860 shares, compared to its average volume of 868,233. Grail has a fifty-two week low of $12.33 and a fifty-two week high of $24.92. The firm’s 50-day simple moving average is $18.32.

Insiders Place Their Bets

In other news, CFO Aaron Freidin sold 30,452 shares of Grail stock in a transaction on Monday, November 18th. The stock was sold at an average price of $14.02, for a total value of $426,937.04. Following the completion of the sale, the chief financial officer now owns 268,277 shares of the company’s stock, valued at $3,761,243.54. The trade was a 10.19 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the business. 180 Wealth Advisors LLC acquired a new position in shares of Grail in the fourth quarter worth about $1,681,000. Douglas Lane & Associates LLC bought a new stake in Grail in the fourth quarter valued at about $3,034,000. B & T Capital Management DBA Alpha Capital Management bought a new stake in Grail in the fourth quarter valued at about $387,000. FNY Investment Advisers LLC bought a new stake in Grail in the fourth quarter valued at about $26,000. Finally, A. D. Beadell Investment Counsel Inc. bought a new stake in Grail in the fourth quarter valued at about $430,000.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the company. Morgan Stanley assumed coverage on Grail in a report on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 target price on the stock. Wolfe Research assumed coverage on Grail in a report on Friday, November 15th. They issued a “peer perform” rating on the stock. Finally, Guggenheim assumed coverage on Grail in a report on Thursday, October 17th. They issued a “neutral” rating on the stock.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.